Form 4: Greenwich LifeSciences CEO Snehal Patel Acquires 3,000 Shares of Common Stock
SEC Form 4
Greenwich LifeSciences CEO Snehal Patel reports the acquisition of 3,000 shares of common stock at a price of $19.08 per share on April 1, 2024.
Summary
- On April 1, 2024, Snehal Patel, CEO and CFO of Greenwich LifeSciences, Inc., acquired 3,000 shares of common stock.
- The purchase price was $19.08 per share.
- Following the transaction, Patel directly owns 5,350,777 shares of Greenwich LifeSciences common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction report. The CEO's purchase could be seen as a slightly positive signal, but it's not a major event.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of transaction: Snehal Patel acquired 3,000 shares of common stock. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.